|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
261200800001E-51
|
$238,204,440
|
$83,354
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Cancer Center Support Grant
|
5P30CA008748-47
|
$13,185,550
|
$131,856
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Comprehensive Cancer Center Core Support Grant
|
5P30CA013148-40
|
$5,476,332
|
$109,527
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support Grant
|
5P30CA091842-11
|
$4,380,520
|
$87,610
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-49
|
$4,061,662
|
$284,316
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Cancer Center Support Grant
|
5P30CA030199-31
|
$3,886,604
|
$349,794
|
VUORI, KRISTIINA
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIEBC010764
|
$3,777,796
|
$755,559
|
Wayne, Alan
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
5P30CA016087-32
|
$2,512,026
|
$25,120
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
SARC Sarcoma SPORE
|
1U54CA168512-01
|
$2,300,000
|
$207,000
|
POLLOCK, RAPHAEL
|
SARC
|
|
Cancer Center Support Grant
|
5P30CA142543-03
|
$1,425,001
|
$42,750
|
WILLSON, JAMES
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Carbohydrate-Dependent Adhesion in Normal and Tumor Cells
|
5P01CA071932-15
|
$1,395,034
|
$1,395,034
|
FUKUDA, MINORU
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-14
|
$1,237,416
|
$37,122
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,137,642
|
$79,635
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Therapies for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIABC010801
|
$954,356
|
$954,356
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
|
5U01CA141549-04
|
$754,845
|
$249,099
|
Gutmann, David
|
WASHINGTON UNIVERSITY
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIABC010539
|
$592,136
|
$236,854
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Mechanism of Merlin-mediated contact inhibition and tumor suppression.
|
5R01CA152975-03
|
$547,633
|
$547,633
|
GIANCOTTI, FILIPPO
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIABC010390
|
$539,792
|
$107,958
|
Tessarollo, Lino
|
CCR (NCI)
|
|
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1
|
5R01CA142928-03
|
$395,129
|
$395,129
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
The Role of p21-Activated Kinases in Malignant Mesothelioma
|
5R01CA148805-02
|
$369,695
|
$369,695
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
Study of Anti-Survival signals in NF1
|
1R01CA153354-01A1
|
$361,050
|
$361,050
|
CHEN, CHANGYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-08
|
$331,162
|
$331,162
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics
|
1R01CA166593-01
|
$329,579
|
$329,579
|
Le, Lu
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
|
5R01CA074177-15
|
$312,768
|
$312,768
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
STROMAL CONTRIBUTIONS TO NF1 GLIOMA FORMATION AND GROWTH
|
5R01CA136573-04
|
$305,938
|
$305,938
|
RUBIN, JOSHUA
|
WASHINGTON UNIVERSITY
|
|
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
|
1R01CA164295-01A1
|
$301,772
|
$150,886
|
Karajannis, Matthias
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
|
ZIABC011240
|
$296,431
|
$59,286
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
|
5R01CA122804-05
|
$291,849
|
$291,849
|
CARROLL, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Elucidating the Function of the NF1 Tumor Suppressor and its Effector Pathways in
|
5R01CA111754-08
|
$284,709
|
$284,709
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Substrate Profiling of Protein Tyrosine Phosphatases
|
5R01CA132855-04
|
$259,419
|
$77,826
|
Pei, Dehua
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA008748-47S3
|
$250,001
|
$2,500
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-40S2
|
$250,000
|
$5,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Building Libraries with Chemical Diversity for Screening
|
ZIABC011469
|
$232,561
|
$46,512
|
Beutler, John
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIABC011470
|
$232,561
|
$46,512
|
Beutler, John
|
CCR (NCI)
|
|
Clinical and Genetic Studies of Neurofibromatosis Type 1
|
ZIA CP010144-10567
|
$228,108
|
$228,108
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Axl receptor signaling in MPNST; potential node for therapy
|
1K08CA160443-01A1
|
$170,618
|
$85,309
|
TORRES, KEILA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S3
|
$170,000
|
$11,900
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Histologic and Molecular Characterization of Solid Pediatric Tumors
|
ZICSC009431
|
$169,694
|
$25,454
|
Tsokos, Maria
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIABC010540
|
$169,182
|
$118,427
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Bioinformatic Tools in Cancer Research
|
ZIHBC010470
|
$161,950
|
$8,097
|
Buetow, Kenneth
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA030199-31S1
|
$142,912
|
$12,862
|
VUORI, KRISTIINA
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S2
|
$140,000
|
$9,800
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S1
|
$115,518
|
$8,087
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S1
|
$107,715
|
$3,231
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIABC010541
|
$84,591
|
$59,214
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
|
3U01CA141549-04S1
|
$82,601
|
$27,258
|
Gutmann, David
|
WASHINGTON UNIVERSITY
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S4
|
$75,000
|
$5,250
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S2
|
$75,000
|
$2,250
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer Center Support Grant
|
3P30CA008748-47S1
|
$75,000
|
$750
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-40S1
|
$75,000
|
$1,500
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Total relevant funding to Neurofibromatosis for this search: $9,713,169
|